Profile data is unavailable for this security.
About the company
Colgate-Palmolive (India) Limited is primarily focused on oral care and personal care in the Indian market. The Company manufactures and markets a range of oral care essentials under the Colgate brand, including toothpastes, toothpowder, toothbrushes, mouthwashes and rinses, and specialty products such as professional grade oral care products. Additionally, its Palmolive brand offers a specialized range of personal care products. Its products include Colgate Strong Teeth toothpaste with Arginine, Colgate MaxFresh toothpaste with Ultrafreeze technology, Colgate Active Salt toothpaste with superior efficacy, Colgate Zig Zag toothbrush with superior aesthetics & packaging, Colgate Super Junior Toothbrush, and Palmolive's three variants include (Forever Happy, Sweet Delight, Alluring Love). It collaborates through its distributor's network or otherwise with a network of diverse wholesalers, modern trade stores, e-commerce and other retailers to make their products available to customers.
- Revenue in INR (TTM)60.01bn
- Net income in INR14.69bn
- Incorporated1937
- Employees2.22k
- LocationColgate-Palmolive (India) LtdColgate Research CentreMain Street, Hiranandani Gardens, PowaiMUMBAI 400076IndiaIND
- Phone+91 2 267095050
- Fax+91 2 225705088
- Websitehttp://www.colgate.co.in/en/in/oc
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Proya Cosmetics Co Ltd | 123.67bn | 16.85bn | 427.71bn | 2.97k | 25.80 | 7.59 | -- | 3.46 | 3.59 | 3.59 | 26.38 | 12.21 | 1.48 | 2.94 | 44.81 | 3,575,240.00 | 20.60 | 15.54 | 28.47 | 21.61 | 68.52 | 66.58 | 13.92 | 12.83 | 2.49 | -- | 0.1538 | 30.15 | 39.45 | 30.41 | 46.06 | 32.97 | -4.80 | 42.52 |
| Procter & Gamble Hygiene & Health Care | 42.03bn | 6.76bn | 512.89bn | 439.00 | 75.85 | -- | 70.25 | 12.20 | 208.32 | 208.32 | 1,294.64 | -- | -- | -- | -- | 95,729,160.00 | -- | 33.42 | -- | 62.37 | 62.16 | 49.77 | 16.09 | 16.20 | -- | 34.89 | -- | 85.09 | 7.35 | 7.37 | -0.4601 | 10.00 | 22.65 | 17.25 |
| Giant Biogene Holding Co Ltd | 51.97bn | 20.60bn | 544.98bn | 1.51k | 25.43 | 7.83 | 25.97 | 10.49 | 1.92 | 1.92 | 4.86 | 6.24 | 0.7649 | 2.96 | 31.08 | 4,118,856.00 | 30.24 | -- | 36.89 | -- | 82.74 | -- | 39.53 | -- | 3.62 | -- | 0.0002 | -- | 49.05 | -- | 44.88 | -- | -- | -- |
| Shiseido Co Ltd | 528.32bn | 1.08bn | 594.98bn | 30.54k | 551.82 | 1.83 | 13.54 | 1.13 | 4.97 | 4.97 | 2,435.08 | 1,498.75 | 0.7625 | 1.45 | 6.71 | 31,872,130.00 | 0.3099 | 2.91 | 0.4583 | 4.39 | 76.26 | 73.51 | 0.4064 | 3.52 | 0.6836 | -- | 0.3466 | 75.17 | -8.84 | -2.33 | -36.41 | -18.75 | -10.63 | 5.92 |
| Colgate-Palmolive (India) Ltd | 60.01bn | 14.69bn | 743.47bn | 2.22k | 50.61 | 44.98 | 45.45 | 12.39 | 54.01 | 54.01 | 220.65 | 60.77 | 1.89 | 5.46 | 34.10 | 27,021,510.00 | 46.22 | 37.35 | 82.27 | 63.15 | 70.10 | 60.82 | 24.48 | 20.89 | 1.08 | 368.18 | 0.0407 | 108.26 | 8.69 | 4.95 | 26.41 | 11.28 | -11.45 | 15.85 |
| Dabur India Ltd | 124.47bn | 17.89bn | 900.60bn | 5.37k | 50.43 | 8.69 | 41.27 | 7.24 | 10.08 | 10.08 | 70.10 | 58.47 | 0.7994 | 3.07 | 11.71 | 23,183,830.00 | 11.30 | 14.50 | 16.28 | 20.25 | 48.56 | 47.82 | 14.14 | 15.82 | 0.9084 | 12.57 | 0.1397 | 49.55 | 7.58 | 7.77 | 7.94 | 5.02 | 19.20 | 0.00 |
| Holder | Shares | % Held |
|---|---|---|
| First Sentier Investors (Hong Kong) Ltd.as of 31 Jul 2024 | 7.49m | 2.75% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 4.87m | 1.79% |
| Life Insurance Corporation of India (Investment Portfolio)as of 30 Jun 2024 | 4.50m | 1.66% |
| BlackRock Fund Advisorsas of 07 Nov 2024 | 3.79m | 1.40% |
| SBI Funds Management Ltd.as of 31 Oct 2024 | 2.46m | 0.90% |
| Axis Asset Management Co. Ltd.as of 31 Oct 2024 | 1.74m | 0.64% |
| Robeco Institutional Asset Management BVas of 30 Sep 2024 | 1.67m | 0.61% |
| The Caisse de d�p�t et placement du Qu�becas of 31 Dec 2023 | 1.44m | 0.53% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 1.38m | 0.51% |
| BlackRock Advisors (UK) Ltd.as of 08 Nov 2024 | 1.37m | 0.51% |
